Ecrina
Menu

Treatment · surgery

Endoscopic thoracic sympathectomy (ETS): last-resort surgical context

Endoscopic thoracic sympathectomy (ETS) is a surgical procedure that cuts or clamps the sympathetic nerve chain in the upper thorax to reduce sweating, primarily in the palms and face. It is highly effective for severe excessive hand sweating but carries the risk of compensatory sweating — increased sweating elsewhere on the body that can be permanent. Modern practice reserves ETS for severe disease that has failed all less-invasive options.

At a glance

Mechanism of action

Sympathetic nerves originating in the upper thoracic spinal cord drive eccrine sweat glands in the upper body. ETS interrupts (by cutting, clamping, or cauterizing) the sympathetic chain at specific thoracic levels (typically T2-T4 for hand and face and scalp disease) to abolish sympathetic input to those regions.

Why ETS is presented as a last-resort context

Ecrina presents ETS as informational context, not as a treatment to seek. Modern practice has narrowed the indication: less invasive treatments (Botox, iontophoresis, pills that reduce sweating) have improved enough that ETS is reserved for severe excessive hand sweating (HDSS 4) that has not responded to less invasive options, with explicit informed consent about compensatory sweating risk. ETS for isolated underarm disease is rarely recommended given the availability of miraDry, Brella, Botox, and skin treatments.

Compensatory sweating risk

Compensatory sweating, defined as increased sweating in regions not targeted by surgery (trunk, lower back, thighs), affects a meaningful proportion of ETS patients and can be permanent. The risk varies by surgical level, technique, and individual patient. For some patients, compensatory sweating is worse than the original problem. This risk is the central consideration in the modern indication for ETS.

Effect on hand disease

Hand sweating typically resolves immediately after ETS, within hours of the procedure. The hands become dry, often unusually dry compared with baseline. Patient satisfaction with hand drying is high in the immediate post-operative period but is moderated over time by compensatory sweating in other regions.

Effect on face and scalp disease

Face and scalp sympathetic innervation is at higher thoracic levels (T2 in particular) and surgery for face and scalp disease can produce additional risks including Horner's syndrome (drooping eyelid, constricted pupil, decreased facial sweating on one side). Many surgeons decline to operate at T2 for face and scalp disease alone because of this risk; treatment alternatives are often preferred.

When ETS is reasonable to discuss

Discussion of ETS is reasonable when: (1) HDSS 4 hand (and sometimes face and scalp) disease, (2) demonstrated failure of or intolerance to antiperspirants applied to the skin, iontophoresis, Botox, and pills that reduce sweating, (3) patient understands the compensatory-sweating risk and accepts it as a tradeoff, (4) consultation with an experienced thoracic surgeon with excessive sweating-specific experience. ETS is irreversible; clamping techniques offer some reversibility but the practical reversibility window is limited.

Practical considerations

  • Next step: surgical procedure under general anesthesia
  • Frequency: one-time procedure (irreversible)
  • Cost class: high; insurance coverage variable
  • Supervision: experienced thoracic surgeon required
  • Region: hand primarily; face and scalp cautiously; underarm rarely

Side effects and reasons this may not be safe for you

  • Compensatory sweating (potentially permanent, can be severe)
  • Horner's syndrome (especially with T2 surgery)
  • Pneumothorax (procedural risk)
  • Bradycardia and reduced exercise heart rate
  • Surgical infection or bleeding
  • Irreversibility (clamping offers limited reversibility window)

Governed citations

Numbers and approved uses on this page link back to their sources governed in anna-pipeline. Each entry below is a packet bound to this treatment.

Efficacy

Safety

Irreversibility

Frequently asked

Should I get ETS for my excessive hand sweating?
Modern practice reserves ETS for severe hand disease that has failed less invasive options. If you have not yet tried antiperspirants applied to the skin, iontophoresis, Botox, and pills that reduce sweating, ETS is typically not the next step. The compensatory sweating risk is real and can be permanent. Discussion with an experienced thoracic surgeon who specifically treats excessive sweating is appropriate when other options have been exhausted.
Is ETS reversible?
Surgical techniques vary. Cutting techniques are irreversible. Clamping techniques offer some reversibility if the clamp is removed within a limited window — typically months rather than years — and even then complete recovery of pre-operative function is not guaranteed. Treat ETS as effectively irreversible when weighing the decision.
Why doesn't Ecrina recommend ETS?
Ecrina is not a surgical practice and does not provide medical recommendations. This page is informational context about an option that exists in the literature and may be discussed with a specialist for severe disease unresponsive to other options. The page exists so people researching ETS have an accurate description of the procedure, the indication, and the compensatory-sweating risk before consulting a surgeon.

Reading paths

When this treatment is usually considered

Step 01

Antiperspirants applied to the skin

Step 02a

Prescription skin treatments that reduce sweating

Step 02b· alternative

Iontophoresis

Step 03

Pills that reduce sweating

pill that reduces sweating

Ditropan · oxybutynin

Regions
underarm, hand, foot, face and scalp, in several separate areas, generalized
Severity fit
HDSS 3, HDSS 4
Type
oral drug
FDA
off label for excessive sweating
Read Ditropan
Step 04

Injectable and in-office procedures

Step 05

Surgery (ETS) — last-resort context